Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Bao, Wei ^a   Song, Fangfang ^a,b   Li, Xiangyang ^a   Rong, Shuang ^a   Yang, Wei ^a   Zhang, Muxun ^a   Yao, Ping ^a   Hao, Liping ^a   Yang, Nianhong ^a   Hu, Frank B ^c,d   Liu, Liegang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEME OXYGENASE 1; INSULIN; TRIACYLGLYCEROL; HMOX1 PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRINKING BEHAVIOR; ENZYME BLOOD LEVEL; ENZYME INDUCTION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PROGNOSIS; SEX DIFFERENCE; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL; AGE; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

AGE FACTORS; ANALYSIS OF VARIANCE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEME OXYGENASE-1; HUMANS; MALE; MIDDLE AGED; SEX FACTORS;

EID: 77957882550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012371     Document Type: Article

References (32)

1. Monnier L, Mas E, Ginet C, Michel F, Villon L, et al. (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295: 1681-1687.
2. Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29: 351-366.
3. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622.
4. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stressactivated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52: 1-8.
5. Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamoto K, et al. (2007) Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal 9: 355-366.
6. Morse D, Choi AM (2002) Heme oxygenase-1: the ''emerging molecule'' has arrived. Am J Respir Cell Mol Biol 27: 8-16.
7. Platt JL, Nath KA (1998) Heme oxygenase: protective gene or Trojan horse. Nat Med 4: 1364-1365.
8. Ryter SW, Alam J, Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650.
9. Tiedge M, Lortz S, Drinkgern J, Lenzen S (1997) Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46: 1733-1742.
10. Jonas JC, Guiot Y, Rahier J, Henquin JC (2003) Haeme-oxygenase 1 expression in rat pancreatic beta cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP. Diabetologia 46: 1234-1244.
11. Won KC, Moon JS, Eun MJ, Yoon JS, Chun KA, et al. (2006) A protective role for heme oxygenase-1 in INS-1 cells and rat islets that are exposed to high glucose conditions. J Korean Med Sci 21: 418-424.
12. Laybutt DR, Glandt M, Xu G, Ahn YB, Trivedi N, et al. (2003) Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes. J Biol Chem 278: 2997-3005.
13. Song F, Qi X, Chen W, Jia W, Yao P, et al. (2007) Effect of Momordica grosvenori on oxidative stress pathways in renal mitochondria of normal and alloxan-induced diabetic mice. Involvement of heme oxygenase-1. Eur J Nutr 46: 61-69.
14. Sato T, Takeno M, Honma K, Yamauchi H, Saito Y, et al. (2006) Heme oxygenase-1, a potential biomarker of chronic silicosis, attenuates silica-induced lung injury. Am J Respir Crit Care Med 174: 906-914.
15. Mateo I, Infante J, Sanchez-Juan P, Garcia-Gorostiaga I, Rodriguez-Rodriguez E, et al. (2010) Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease. Acta Neurol Scand 121: 136-138.
16. Miyazaki T, Kirino Y, Takeno M, Hama M, Ushihama A, et al. (2010) Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions. Int J Hematol 91: 229-237.
17. Song F, Li X, Zhang M, Yao P, Yang N, et al. (2009) Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population. Am J Epidemiol 170: 747-756.
18. Avogaro A, Pagnin E, Calo L (2003) Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress. J Clin Endocrinol Metab 88: 1753-1759.
19. Calabrese V, Mancuso C, Sapienza M, Puleo E, Calafato S, et al. (2007) Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12: 299-306.
20. Bruce CR, Carey AL, Hawley JA, Febbraio MA (2003) Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 52: 2338-2345.
21. Adaikalakoteswari A, Balasubramanyam M, Rema M, Mohan V (2006) Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with Type 2 diabetes and microangiopathy. Diabet Med 23: 666-674.
22. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
23. Song F, Jia W, Yao Y, Hu Y, Lei L, et al. (2007) Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci (Lond) 112: 599-606.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
25. Zhou BF (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15: 83-96.
26. Abraham NG, Kappas A (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127.
27. Poss KD, Tonegawa S (1997) Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 94: 10925-10930.
28. Poss KD, Tonegawa S (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 94: 10919-10924.
29. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, et al. (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135.
30. Schipper HM (2004) Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med 37: 1995-2011.
31. Schipper HM, Chertkow H, Mehindate K, Frankel D, Melmed C, et al. (2000) Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology 54: 1297-1304.
32. Kirino M, Kirino Y, Takeno M, Nagashima Y, Takahashi K, et al. (2008) Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice: implications for human disease. J Allergy Clin Immunol 122: 290-297, 297 e291-298.